Mapping the Hidden Structure of Glioma Research: What Are We Missing?
Unlike previous studies that focused primarily on metrics such as the h-index, our approach identifies... read more
May 5, 2026
Oncotarget News
SCD1 Inhibition Strategy Shows Potent Synergy with Regorafenib and Metformin in Tumor Cell Killing
Our data demonstrates that UM cells are killed by treatment with aramchol plus regorafenib plus... read more
April 21, 2026
Oncotarget Editorial Highlights Advances in Scientific Integrity and Publishing Transparency
Scientific integrity is a crucial component of scholarly publishing.”BUFFALO, NY – April 10, 2026 – ... read more
April 10, 2026
CREB5: A Master Regulator of Stem Cell-Like Programs in Prostate Cancer Progression
In this study, through both computational and molecular characterization of PC cell lines, we determined... read more
April 7, 2026
Predicting Colorectal Cancer Survival: How Machine Learning Combines Clinical and Biological Clues
Understanding both the biological and clinical aspects of the patient is essential to uncover the... read more
March 25, 2026
CAR-T Cell Therapy: A Revolutionary Approach to Cancer Treatment
Given the small percentage of patients cured from advanced-stage disease, there is still a considerable... read more
March 10, 2026
mRNA COVID-19 Vaccination and Cancer Risk: A Case-Based Review
The carcinogenic risk associated with these technologies, which has long been known within the gene... read more
February 27, 2026
How HPV and COVID-19 Spike Proteins May Interact to Impact Cancer Suppression
Thus, the present hypothesis is that virally encoded proteins such as HPV-E6 or SARS-COV-2 Spike... read more
February 9, 2026
Exploring Possible Links Between COVID-19 Vaccination, Infection, and Cancer
These findings underscore the need for rigorous epidemiologic, longitudinal, clinical, histopathological, forensic, and mechanistic studies... read more
January 26, 2026
Overcoming Aromatase Inhibitor Resistance in Breast Cancer: A New Therapeutic Strategy
The estrogen receptor is overexpressed in and promotes 67-80% and 90% of female and male... read more
January 13, 2026